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Abstract. Currently, optical biopsy is a promising area of diagnosing the state of 
tissues in real time during the surgical treatment of oncological diseases. The 
important part of this direction is the development of fluorescence imaging 
systems and ensuring the accuracy of the calibration of optical measurements. The 
article describes the development of fluorescence imaging system to define tumor 
surgical resection margins of abdominal organs. In this study, we proposed of 
low-cost optical tissue-mimicking phantom combining solid base and liquid part 
that suitable for quick calibration of fluorescence imaging systems depending on 
the target endogenous fluorophores. The results of two series of experimental 
measurements are described. The first measurements of the optical phantom with 
riboflavin mononucleotide (imitating flavin adenine dinucleotide) and 
protoporphyrin IX demonstrated the sensitivity of the developed device to 
proportionally changing concentrations of target fluorophores. The second part of 
the study included in vivo measurements of liver tumors modeled in mice. The 
obtained results showed the ability of the developed fluorescence imaging system 
to register changes in fluorescence due to carcinogenesis. © 2020 Journal of 
Biomedical Photonics & Engineering. 
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According to the World Health Organization statistics, 
oncological diseases remains the second leading cause 
of in mortality worldwide [1]. Approximately 18.1 
million new cases of cancer were detected in 2018 and 
9.6 million deaths from cancer occurred. A significant 
percentage of incidence and mortality rates is occupied 
by malignant tumors and their metastases that develop 
in the abdominal and gastrointestinal organs (liver, 
pancreas, stomach, esophagus, colon, rectum, etc.). One 
of the causes leading to deterioration of prognosis in 
patients is the difficulties in accurate diagnosis of area 
and depth of malignant infiltration during the surgical 
treatment. 
The leading method for treating many malignant 
tumors including abdominal and gastrointestinal ones is 
surgery [2–4]. The surgical treatment is aimed at safely 
removing as much of the tumor tissue without the 
necessity of additional surgery as possible. The main 
challenge surgeons face in this case is accurate 
definition of resection margins during the surgery. 
Detection and differentiation of intact and tumor tissue 
before and during surgical treatment is usually done by 
palpation and visual examination followed by 
intraoperative histopathological analysis of samples 
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taken from suspicious tissue sites. Visual inspection in 
white light and palpation are limited in sensitivity and 
subjectivity of visual and tactile sensations of the 
surgeon as it is hard to clearly distinguish the presence 
of the tumor tissue at the places of resection. A 
procedure express biopsy of each tissue sample takes 
about 20–25 min, which significantly increases the 
duration of the surgery and may pose risks to the 
patient. Moreover, the samples are usually taken 
randomly from several places of resection edge, which 
enhances the probability of a false negative result and 
can lead to cancer reversal in up to 19% of cases [5, 6]. 
In this regard, the problem of developing new 
diagnostic methods that allow the surgeon to receive 
additional diagnostic information on localization of 
malignant tissues in the resection margin in real time 
remains relevant direction of medical and biomedical 
engineering research. 
Currently, one of the most promising and rapidly 
developing areas of real-time diagnostics for solving 
surgical treatment problems is a large number of optical 
methods often combined in the literature by the term 
“optical biopsy” [7–10]. These methods are aimed at 
providing the results comparable to data obtained by 
traditional methods without the requirement to acquire a 
tissue sample and spend considerable amount of time to 
perform the analysis. Optical biopsy includes 
spectroscopy and imaging techniques used to assess 
various parameters of morphology and metabolism of 
biological tissues in vivo [11, 12]. Additional diagnostic 
information can increase the effectiveness of surgical 
treatment of cancer in general and provide decision 
making support for organ preserving treatment. 
One of the optical effects widely used to study 
metabolic activity is fluorescence. Fluorescence 
diagnostic methods are based on probing the tissue with 
monochromatic radiation of the near ultraviolet or 
visible range, exciting the fluorescence of endogenous 
or exogenous fluorophores and recording secondary 
emission for further analysis. Two most popular 
approaches – fluorescence spectroscopy (FS) and 
fluorescence imaging (FI) – demonstrate significant 
sensitivity to the presence of pathological changes in 
tissues, in particular malignant ones [13–15]. Extensive 
studies have been conducted in this direction for several 
decades to develop methodologies and devices for 
effective distinguishing of normal and tumor tissues in 
various human organs (lungs, breast, colon, cervix, etc.) 
[16–18]. 
Currently, a number of systems for fluorescence-
guided surgery have already been clinically tested and 
implemented in the practice of surgeons. However, 
many of these systems involve the use of special 
fluorescent dyes for optical diagnostics in the near 
infrared range [19]. On the other hand, changes in 
autofluorescence caused by altered metabolic processes 
are also studied for the purpose of malignancies 
diagnosis [10, 20, 21]. 
It is known that cells undergo malignant 
transformations during carcinogenesis proceed which 
lead to morphological and biochemical changes 
detectable by fluorescence methods. The metabolic rate 
activity affects the content of certain fluorophores, such 
as nicotinamide adenine dinucleotide (NAD) and flavin 
adenine dinucleotide (FAD). These coenzymes are 
contained in the cytosol and mitochondria and are 
involved in reactions providing cells with energy, acting 
as electron donors and acceptors. These substances 
undergo oxidation and reduction reactions and reduced 
NAD (NADH) and oxidized FAD demonstrate the 
greatest contribution to tissue fluorescence. Maximum 
NADH fluorescence emits in blue light under 365 nm 
excitation, while FAD fluorescence emits in green light 
under 450 nm excitation [20]. Several clinical studies 
show that oncological processes affect such parameters 
as fluorescence intensity and redox ratio (FAD/NADH) 
[22]. Active proliferation in hypoxia forces tumor cells 
to switch to a glycolytic type of metabolism. These 
conditions lead to an increase in the concentration of 
NADH, change in redox ratio of FAD and NADH 
(FAD/NADH) [23–25]. Several clinical studies of FAD 
in tumors showed the changes in its fluorescence 
associated with oncological processes as well [26–28]. 
As FAD is involved in several metabolic reactions 
(tricarboxylic acid cycle, oxidative phosphorylation, 
acetyl coenzyme A synthesis, etc.) [29], the increase in 
FAD fluorescence can be explained by an increase in 
metabolic activity in abnormal tissues, which indicates 
tumor growth [30]. 
It is also reported that oncological processes cause 
abnormal increase of porphyrins accumulation, which 
indicates specific metabolic disorders of tumor cells [23, 
31]. Porphyrin, namely protoporphyrin IX (PpIX), 
accumulates in tumors more actively [32–34], which is 
widely used in photodynamic therapy. Autofluorescence 
diagnostics of porphyrins has sufficient sensitivity to the 
presence of tumor sites as well [35]. 
Thus, the contribution of the listed fluorophores 
(NADH, FAD, porphyrins) to the spectra of endogenous 
fluorescence is closely dependent on the state of the 
tissue, which indicates the relevance of the development 
of methodologies and technical implementation for their 
registration and analysis.  
While the FS and FI methods can be successfully 
used for the fluorescence contrasting at the selected 
wavelength of the emission [36], the fluorescence 
measurements of endogenous fluorophores in living 
tissues can be challenging due to the overlap of the 
emission spectra of different fluorophores. Moreover, 
biological tissues are heterogeneous complex structures 
containing various fluorophores in different 
concentrations and at different depths [37, 38]. In order 
to correctly interpret the experimental data in future 
clinical applications, it is necessary to determine the 
contribution of each component to the total signal. For 
this purpose, researchers usually perform test 
measurements using normal or pathologically altered 
tissues of laboratory animals or specially designed 
optical phantoms. While the studies in model animals 
are more close to real conditions of clinical in vivo 
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measurements, they are also more resource consuming 
and it is harder to imitate certain optical properties. 
Optical phantoms allow one to mimic the typical 
interaction of optical radiation with biological tissue 
with determined parameters of absorption, scattering, 
fluorescence, etc., which can be implemented both as 
test method at the stage of development and as the 
calibration method for future routine running in 
practice. The images of optical phantoms can be also 
used to improve resolution and quantification of 
uncorrected images using, for example, the 
deconvolution method [39]. 
Currently, researchers use several forms of optical 
phantoms in their studies in order to reach the versatility 
of properties mimicked, decrease the cost of the 
phantom and ensure the quality conform to the 
application goal. Most of the phantom spectroscopic 
studies available in literature are based on the 
development of liquid phantoms, which are used for 
modelling infinite or semi-infinite single layer media 
with absorption, scattering and fluorescence effects [40, 
41]. For imitation of soft tissue-mimicking fluorescence 
gel-wax phantom based on mineral-oil material is 
known to be created [42]. 
The concept of a thin solid optical tissue phantom to 
maintain the required geometrical shape, thickness and 
inhomogeneity similar to multi-layered tissues is a 
challenging task. Various materials are used to create 
this phantoms, such as epoxy, polyester resin, or 
polyurethane material, which provide the photostability 
needed in long-term imaging applications [43–45]. 
Several scientific studies describe single-layer and two-
layer solid gelatin phantoms fabricated for fluorescence 
studies, which are used to mimic normal and dysplasia 
tissue conditions [46, 47]. In this case, gelatin is used to 
imitate the fluorescence of collagen, as this protein is 
the main structural component of connective tissues.  
Therefore, the aim of this work was the development 
of FI system and an optical tissue-mimicking phantom 
for its calibration as a preliminary stage of complex 
development of FI technology for detecting tumor 
margins during the surgery. As a target endogenous 
fluorophores for this study, FAD and PpIX were chosen. 
As simplicity and accessibility should play an important 
role in development and using of this technology, the 
main objective of this study was to assess the 
possibilities of development of low-cost phantom. 
2 Materials and Methods 
2.1 Experimental Setup 
The scheme of the experimental home-built setup 
developed in this study is presented in Fig. 1.  
The excitation channel included 455 nm LLS-455 
LED source (Ocean Optics, USA) to excite the 
endogenous fluorescence. The radiation from the source 
was directed through a condenser and MF445-45 
bandpass filter (Thorlabs, Inc. USA) to the object to cut 
a narrow band of excitation and minimize the effect of 
other tissue fluorophores. The diameter of the 
illuminated spot was adjusted with a collimator in the 
range from 1 to 3 cm. The image recording channel 
included FGL495 and FGL610 glass filters (Thorlabs, 
Inc. USA) with cut-off wavelengths of 495 nm and 610 
nm to attenuate backscattered source radiation and pass 
the certain bands of fluorescence radiation to the 
detector. The images were recorded by 340M-USB fast 
frame rate monochrome scientific CCD camera 
(Thorlabs, Inc. USA). The camera’s area of interest was 
2.5 cm in diameter. The camera is controlled by the 
standard ThorCam software (Thorlabs, Inc. USA).  
 
 
Fig. 1 The scheme of the experimental setup. 
The FS method used for additional control 
measurements was implemented by the multifunctional 
laser diagnostic complex LAKK-M (SPE “LAZMA” 
Ltd, Russia). This device provided fluorescence 
excitation at 365 nm and 450 nm wavelengths and was 
equipped with 3 mm optical fiber probe (400 µm fibers, 
NA = 0.22). The spectra were recorded by the built-in 
spectrometer in the range of 340–800 nm. 
In addition, the stabilized broadband radiation 
source of 360–2600 nm range SLS201L-M (Thorlabs 
Inc., USA) was used to record white light images and 
compare them with fluorescence images. 
2.2 Tissue-mimicking Phantom Development 
The idea of the optical phantom designed in this work 
was to combine the solid base for modeling of 
background collagen fluorescence and the liquid part to 
mimic the various concentrations of FAD and porphyrin 
fluorescence in biological tissues.  
To produce optical phantoms imitating collagen 
fluorescence, it is possible to use gelatin, which is its 
hydrolyzed form. In this work, we created a multi-layer 
model consisting of sheets of gelatin with a thickness of 
less than 1 mm and a weight of less than 5 g. The 
optimal number of gelatin sheets was experimentally 
selected by comparing the fluorescence intensity levels 
of gelatin sheets and skin collagen. To simulate the 
FAD fluorescence spectrum, a 1% solution (26.6 µM/g) 
of riboflavin mononucleotide was used. This substance 
belongs to the flavin group and has the fluorescence 
spectrum similar to the spectrum of FAD. Riboflavin 
has a higher quantum yield, and, unlike FAD, its 
quantum yield within pH 4–8 does not depend on 
acidity [48]. It is known that the concentration of FAD 
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in human body usually varies from 0.1 to 1 µM/g [49]. 
In accordance with this data, four concentrations of 
riboflavin were selected close to the real concentrations 
of FAD in biological tissues. The solution of riboflavin 
mononucleotide was diluted with distilled water in the 
following ratios: 1:32, 1:64, 1:128 and 1:256. Thus, the 
solid base of the optical phantom was composed of two 
sheets of gelatin. The liquid part was made of the 
solutions of four different concentrations (0.84; 0.42; 
0.21; 0.1 µM/g) of riboflavin distributed in four 
different areas of the phantom.  
In our research, we used PpIX obtained chemically 
from the dark eggshell. It is known that PpIX, an 
immediate precursor of heme, is the main pigment that 
create the shell color [50]. Before the extraction, the 
eggshells were thoroughly washed of albumen and shell 
membranes and dried. 10 g of the eggshells were mixed 
with 150 ml of a 1 M hydrochloric acid solution. The 
reacting mixture was maintained until the release of 
carbon dioxide ceased. The undissolved residue was 
separated by filtration through a paper filter. The 
resulting emulsion was centrifuged to completely 
separate the layers. The top layer containing PpIX was 
transferred to a conical flask and 10 g of pre-calcined 
sodium sulfate was added to PpIX. The PpIX solution 
was separated from the salt by decantation and 
evaporated in a hot water bath until the solvent was 
completely removed. The residue was dissolved in 5 ml 
of dimethyl sulfoxide. As a result, PpIX was obtained at 
a concentration of 0.3 µM/g, which was applied to two 
sheets gelatin model similar to riboflavin.   
The research methodology included sequential 
registration of fluorescence images using the CCD 
camera and the spectrometer. Drops of the same volume 
(20 µl) with different concentrations of riboflavin or 
PpIX were applied to gelatin sheets using a 
micropipette. The resulting phantoms with riboflavin 
and PpIX were located on a non-fluorescent non-
reflective surface. The registration of images was 
carried out in the following order. At the first stage, a 
495 nm filter was installed in front of the camera, and 
fluorescence images were recorded 3 times. Then the 
image of phantoms in white light was recorded without 
a filter. At the second stage, the fluorescence spectra of 
each phantom were recorded 3 times. The results were 
processed on a personal computer using specially 
developed software in the Matlab environment.  
2.3 Animals Model 
The developed FI system demonstrated a rather high 
sensitivity to changes in the concentrations of dysplasia 
markers, such as flavins and porphyrins. In connection 
with this next step was also testing an animal model of 
liver cancer. The studies were approved by the Ethics 
Committee of Orel State University named after I.S. 
Turgenev (protocol No. 10 of 16.10.2017) and were 
carried out in accordance with the principles of Good 
Laboratory Practice [51]. Optical measurements were 
conducted in the BDF (C57Bl6xDBA) laboratory mice 
(male, n = 2, 20 weeks). H33 mouse hepatocellular 
carcinoma culture was previously implanted through a 
syringe into the medial lobe of the liver in a volume of 
100 µl (50,000 cells/µl) per mouse during abdominal 
surgery. After approximately 2 months after the surgery, 
the experiments were carried out as mice increased their 
weight by more than 15% of the normal weight.  
Before the measurements, the animal was 
anesthetized with Zoletil (Vibrac, France) in the 
standard dosage. The animal was fixed on a special 
platform in the back position. A transverse laparotomy 
was performed to gain access to the abdominal cavity. A 
surgeon performed a visual and palpatory examination 
of the abdominal cavity to determine the presence and 
localization of malignant and healthy tissue in the liver 
and other organs. The next step was to place the animal 
under the imaging channel of the experimental set up to 
adjust the focus, frame rate and exposure time according 
to the area of interest.   
The research methodology included step-by-step 
registration of liver and tumor images in white light 
without filters and under 450 nm excitation with optical 
filters to obtain fluorescence images. The measurements 
were repeated 3 times. The obtained data was processed 
on a personal computer using custom developed 
software in the Matlab computing environment. 
 
   
(a) (b) (c) 
Fig. 2 Obtained images of the optical phantom: original image of riboflavin phantom in white light (a), fluorescence 
image of riboflavin phantom (b), fluorescence image of PpIX phantom (c). 
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3 Results and Discussion 
3.1 Tissue-mimicking Phantom 
As a result, the registered images of created optical 
phantom under halogen lamp illumination and LED 
illumination after preliminary processing are presented 
in Fig. 2a–c. The white light images (Fig. 2a) were 
recorded with exposure time of 20 ms, fluorescence 
images (Fig. 2b, c) were recorded with 400 ms exposure 
time. After that, the intensities were normalized to the 
maximum intensity to represent the obtained data in the 
range of [0; 1]. The fluorescence images of PpIX liquid 
on the gelatin surface of developed phantom was also 
recorded (Fig. 2c).  
The intensity values of riboflavin and PpIX 
fluorescence were averaged in similar areas of each 
drop. The maximum fluorescence intensities obtained 
with the FS method were averaged and compared with 
the results of FI. Thereafter, the intensities were 
normalized by the maximum obtained value, so the 
maximum intensity was equal to 1. The results of 
fluorescence intensities measurements for each 
concentration of riboflavin and PpIX using FS modality 
are presented in Fig. 3. 
For the three lowest concentrations of riboflavin, it 
was noticed that the fluorescence intensity recorded by 
FI decreases proportionally to the decrease of 
concentrations. However, the same trend was not 
observed for the highest concentration, which can be 
caused by reaching such concentration, starting from 
which the level of fluorescence intensity becomes 
constant. 
The trend calculated from fluorescence images 
(Fig. 3c) was also confirmed during measurements with 
FS channel. Future studies will be dedicated to the 
combining of the fluorescence measurements with 
hyperspectral technology [52] to develop effective 
compensation algorithms to attenuate the influence of 
tissue/phantom light absorbers (e.g. hemoglobin) on the 
fluorescence intensity recorded.  
Based on the results presented in Fig. 2 and 3с, a 
significant effect of uneven illumination of the optical 
phantom was observed during data processing, which 
suggests the implementation of orthogonal optical 
schemes in future research. 
3.2 Animal Study 
In the course of the study, images of the abdominal 
cavity of two laboratory animals with an experimental 








Fig. 3 Average normalized fluorescence spectra of 
riboflavin (a) and PpIX (b) solutions, fluorescence 






   
(a) (b) (c) 
Fig. 4 The image in white light (a), fluorescence image with 495 nm filter (b) and fluorescence spectra (c) of abdominal 
cavity of mouse 1. 
    
(a) (b) (c) (d) 
Fig. 5 The image in white light (a), fluorescence image with 495 nm filter (b), fluorescence image with 610 nm filter (c) 
and fluorescence spectra (d) of abdominal cavity of mouse 2. 
 
Fig. 4 and 5 show white images, fluorescence 
images and fluorescence spectra of target zones. The 
areas highlighted by a circle 1 correspond to the 
localization of the tumor. The areas highlighted by a 
circle 2 correspond to surrounding intact liver tissues. 
When the light is filtered with 495 nm filter, the 
fluorescence can be visualized mainly in the range of 
500–540 nm. With 610 nm filter, a clear contrast of 
fluorescence is observed in the range of 620–640 nm. 
It should be noted that fluorescence images of 
mouse 1 were obtained only with 495 nm light filter. 
The diameter of the probing area was about 3 cm. 
During the analysis of the initial images of mouse 1, it 
was noted that the tumor was not green colored as it 
should be for the peak of FAD fluorescence (about 
530 nm). Instead, it was yellow, which was presumably 
associated with significant accumulation of porphyrins 
in the tumor and, thus, the summation of fluorescence 
FAD and porphyrins (fluorescence in the range of 620–
640 nm). The FS data confirmed this hypothesis; 
therefore, FI measurements protocol and experimental 
setup were upgraded for the second series of 
measurements. The images of mouse 2 were obtained 
using two filters.  
The values of white light reflectance intensity and 
fluorescence intensity in the highlighted areas were 
averaged to compare the data from the tumor and 
surrounding tissues obtained in white light and 
fluorescence mode. As a result, it was found that while 
the intensity of the tumor reflectance exceeded the 
intensity from unchanged tissue by 1.2 times. 
Fluorescence images demonstrated the value of this 
parameter is 4.2 for 495 nm filtered images and 2.6 for 
610 nm filtered images. This result proves that it is 
possible to more clearly distinguish the tumor focus. An 
increase of fluorescence intensity in malignant tissues 
compared with the surrounding tissues in 495 nm 
filtered images may indicate changes in the content of 
endogenous fluorophores, which in turn are caused by 
metabolic disorders accompanying carcinogenesis 
process.  
The images of mouse 2 under 495 nm filter did not 
demonstrate the same pronounced yellow color in the 
tumor. The fluorescence spectra (Fig. 4c and Fig. 5d) 
demonstrated that the accumulation of PpIX 
fluorescence in the tumor of mouse 1 was greater than 
in mouse 2. Based on the analysis of the obtained 
images and spectra, it was noticed that the 
carcinogenesis processes occurred individually in each 
animal, which should also be taken into account when 
planning and conducting further experimental studies.  
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Thus, the obtained images and the calculated 
differences in the tumor/intact tissue ratio of average 
fluorescence intensity indicate a high sensitivity of FI 
technique to the presence of malignant changes in the 
tissues compared to conventional images recorded in 
white light. Depending on the fluorescence intensity 
increase degree, a more accurate determination of the 
accumulation sites of various fluorophores in the tissue 
structure of the organ is possible in vivo. At the same 
time, the FS method can also provide additional 
information for the correct interpretation of the FI data. 
In this regard, the use of hyperspectral technologies for 
measuring the fluorescence of biological tissues is 
promising. 
4 Conclusion 
Many researchers work on the development of technical 
implementation and diagnostic criteria for intraoperative 
fluorescence imaging based on the autofluorescence of 
endogenous fluorophores. An important stage of such 
research is the providing of reproducible measurements 
of biological tissues for both the process of development 
itself and for primary and periodic calibration of 
imaging systems during their practical application.  
For these purposes, we developed the experimental 
setup for fluorescence imaging of tissues fluorophores 
associated with metabolic changes and carcinogenesis. 
The optical phantom mimicking the biological tissue 
fluorescence was also created for its calibration as a 
preliminary stage of complex development of FI 
technology for cancer detection during surgery. 
These studies showed the possibility of application 
of the developed fluorescence imaging system for 
obtaining real-time information about the presence of 
malignant cells on the resection margin in cancer 
surgery. The implementation of FI technology to 
clinical practice can increase the effectiveness of 
surgical interventions in the long term by reducing time 
spend on surgeries and reducing the probability of a 
false negative error during the defining of the resection 
margin.  
The proposed phantom is relatively simple to 
manufacture and use for measurements. The phantom 
mimics tissue fluorescence for specific research tasks, 
taking into account the presence of collagen. As an 
option for further research in this direction, it is planned 
to develop a more complex optical model of biological 
tissue using other endogenous fluorophores, such as 
NADH and FAD themselves. The obtained 
experimental data indicate the sensitivity of the 
developed fluorescence phantom to changes in the 
concentration of flavins, as well as the presence of 
PpIX. 
Application of the developed optical phantom will 
allow to more accurately test the FI systems and 
improve the overall quality of implementation of this 
technology. The data obtained will be used to correct 
fluorescence images of pathological biological tissues 
and to more clearly determine the resection margins. 
Further research will be aimed at improving the 
technical implementation and the optical phantom, as 
well as conducting reliable and reproducible 
experimental measurements of normal and tumor tissue 
parameters to develop diagnostic criteria and introduce 
fluorescence imaging technology into clinical practice. 
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